Recombinant Human Lgr5/GPR49 Protein，His

Lgr5, also known as GPR49, is a member of the leucine-rich repeat-containing G protein-coupled receptor family and has garnered significant attention for its role in various biological processes, particularly in stem cell biology and tumorigenesis. Initially identified as a marker for intestinal stem cells, Lgr5 has been shown to play a critical role in maintaining the stem cell niche and regulating cellular proliferation and differentiation. Its interaction with the Wnt signaling pathway suggests that Lgr5 might be pivotal in both normal and malignant tissue homeostasis. Researchers have been exploring Lgr5's potential as a therapeutic target, given its overexpression in several cancers, including colorectal cancer. By studying recombinant Lgr5/GPR49 proteins, scientists aim to elucidate its functional mechanisms and interactions at the molecular level. These investigations not only provide insights into the fundamental biology of stem cells and cancer but also pave the way for developing novel strategies for targeted therapies that can inhibit cancer progression and improve patient outcomes. The production and characterization of Lgr5/GPR49 recombinant proteins facilitate the exploration of its structure-function relationship, aiding in the identification of small molecules or antibodies that could modulate its activity in therapeutic contexts. Overall, the study of Lgr5/GPR49 holds promise for advancing our understanding of stem cell dynamics and cancer biology, addressing critical oncology challenges.